Review



virus strains shcontrol addgene  (Addgene inc)


Bioz Verified Symbol Addgene inc is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 96

    Structured Review

    Addgene inc virus strains shcontrol addgene
    Virus Strains Shcontrol Addgene, supplied by Addgene inc, used in various techniques. Bioz Stars score: 96/100, based on 1096 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/shrna+shcontrol/scramble+shRNA+(Plasmid+%231864)/pm42776838-284-232-235
    Average 96 stars, based on 1096 article reviews
    virus strains shcontrol addgene - by Bioz Stars, 2026-10
    96/100 stars

    Images

    Related Articles

    shRNA:

    Article Title: Heat shock protein family D member 1 mediates lung cancer cell‑induced angiogenesis of endothelial cells
    Article Snippet: shHSPD1 with the following oligonucleotide sequence: 5'-GCTAAACTTGTTCAAGATGTTTCAAGAGAACATCTTGAACAAGTTTAGCTTTTTT-3' was cloned into the pLKO.1-puro plasmid (a gift from Dr Bob Weinberg, Whitehead Institute for Biomedical Research and Department of Biology, Massachusetts Institute of Technology, MA, USA; Addgene plasmid no. 8453). .. The scrambled shRNA (shControl) with the oligonucleotide sequence: 5'-CCTAAGGTTAAGTCGCCCTCGCTCGAGCGAGGGCGACTTAACCTTAGG-3' inserted into the pLKO.1-puro plasmid (a gift from Dr David Sabatini, Whitehead Institute for Biomedical Research and Department of Biology, Massachusetts Institute of Technology, MA, USA; Addgene plasmid no. 1864) served as a negative control. .. Using a third-generation lentivirus system, lentiviral particles were produced by co-transfecting 293T cells (CRL-3216; ATCC) with either pLKO.1-puro-shHSPD1 (6 μg) or pLKO.1-puro-shControl (6 μg), along with packaging plasmids, including pMDLg/pRRE (a gift from Dr Didier Trono, Department of Genetics and Microbiology, Faculty of Medicine, University of Geneva, Switzerland; Addgene plasmid no. 12251), pRSV-Rev (a gift from Dr Didier Trono, Addgene no. 12253), and pCMV-VSV-G (a gift from Dr Bob Weinberg, Addgene plasmid no. 8454) using jetPRIME transfection reagent (Polyplus) for 12 h at 37 ̊C.

    Sequencing:

    Article Title: Heat shock protein family D member 1 mediates lung cancer cell‑induced angiogenesis of endothelial cells
    Article Snippet: shHSPD1 with the following oligonucleotide sequence: 5'-GCTAAACTTGTTCAAGATGTTTCAAGAGAACATCTTGAACAAGTTTAGCTTTTTT-3' was cloned into the pLKO.1-puro plasmid (a gift from Dr Bob Weinberg, Whitehead Institute for Biomedical Research and Department of Biology, Massachusetts Institute of Technology, MA, USA; Addgene plasmid no. 8453). .. The scrambled shRNA (shControl) with the oligonucleotide sequence: 5'-CCTAAGGTTAAGTCGCCCTCGCTCGAGCGAGGGCGACTTAACCTTAGG-3' inserted into the pLKO.1-puro plasmid (a gift from Dr David Sabatini, Whitehead Institute for Biomedical Research and Department of Biology, Massachusetts Institute of Technology, MA, USA; Addgene plasmid no. 1864) served as a negative control. .. Using a third-generation lentivirus system, lentiviral particles were produced by co-transfecting 293T cells (CRL-3216; ATCC) with either pLKO.1-puro-shHSPD1 (6 μg) or pLKO.1-puro-shControl (6 μg), along with packaging plasmids, including pMDLg/pRRE (a gift from Dr Didier Trono, Department of Genetics and Microbiology, Faculty of Medicine, University of Geneva, Switzerland; Addgene plasmid no. 12251), pRSV-Rev (a gift from Dr Didier Trono, Addgene no. 12253), and pCMV-VSV-G (a gift from Dr Bob Weinberg, Addgene plasmid no. 8454) using jetPRIME transfection reagent (Polyplus) for 12 h at 37 ̊C.

    Plasmid Preparation:

    Article Title: Heat shock protein family D member 1 mediates lung cancer cell‑induced angiogenesis of endothelial cells
    Article Snippet: shHSPD1 with the following oligonucleotide sequence: 5'-GCTAAACTTGTTCAAGATGTTTCAAGAGAACATCTTGAACAAGTTTAGCTTTTTT-3' was cloned into the pLKO.1-puro plasmid (a gift from Dr Bob Weinberg, Whitehead Institute for Biomedical Research and Department of Biology, Massachusetts Institute of Technology, MA, USA; Addgene plasmid no. 8453). .. The scrambled shRNA (shControl) with the oligonucleotide sequence: 5'-CCTAAGGTTAAGTCGCCCTCGCTCGAGCGAGGGCGACTTAACCTTAGG-3' inserted into the pLKO.1-puro plasmid (a gift from Dr David Sabatini, Whitehead Institute for Biomedical Research and Department of Biology, Massachusetts Institute of Technology, MA, USA; Addgene plasmid no. 1864) served as a negative control. .. Using a third-generation lentivirus system, lentiviral particles were produced by co-transfecting 293T cells (CRL-3216; ATCC) with either pLKO.1-puro-shHSPD1 (6 μg) or pLKO.1-puro-shControl (6 μg), along with packaging plasmids, including pMDLg/pRRE (a gift from Dr Didier Trono, Department of Genetics and Microbiology, Faculty of Medicine, University of Geneva, Switzerland; Addgene plasmid no. 12251), pRSV-Rev (a gift from Dr Didier Trono, Addgene no. 12253), and pCMV-VSV-G (a gift from Dr Bob Weinberg, Addgene plasmid no. 8454) using jetPRIME transfection reagent (Polyplus) for 12 h at 37 ̊C.

    Negative Control:

    Article Title: Heat shock protein family D member 1 mediates lung cancer cell‑induced angiogenesis of endothelial cells
    Article Snippet: shHSPD1 with the following oligonucleotide sequence: 5'-GCTAAACTTGTTCAAGATGTTTCAAGAGAACATCTTGAACAAGTTTAGCTTTTTT-3' was cloned into the pLKO.1-puro plasmid (a gift from Dr Bob Weinberg, Whitehead Institute for Biomedical Research and Department of Biology, Massachusetts Institute of Technology, MA, USA; Addgene plasmid no. 8453). .. The scrambled shRNA (shControl) with the oligonucleotide sequence: 5'-CCTAAGGTTAAGTCGCCCTCGCTCGAGCGAGGGCGACTTAACCTTAGG-3' inserted into the pLKO.1-puro plasmid (a gift from Dr David Sabatini, Whitehead Institute for Biomedical Research and Department of Biology, Massachusetts Institute of Technology, MA, USA; Addgene plasmid no. 1864) served as a negative control. .. Using a third-generation lentivirus system, lentiviral particles were produced by co-transfecting 293T cells (CRL-3216; ATCC) with either pLKO.1-puro-shHSPD1 (6 μg) or pLKO.1-puro-shControl (6 μg), along with packaging plasmids, including pMDLg/pRRE (a gift from Dr Didier Trono, Department of Genetics and Microbiology, Faculty of Medicine, University of Geneva, Switzerland; Addgene plasmid no. 12251), pRSV-Rev (a gift from Dr Didier Trono, Addgene no. 12253), and pCMV-VSV-G (a gift from Dr Bob Weinberg, Addgene plasmid no. 8454) using jetPRIME transfection reagent (Polyplus) for 12 h at 37 ̊C.



    Similar Products

    96
    Addgene inc virus strains shcontrol addgene
    Virus Strains Shcontrol Addgene, supplied by Addgene inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/shrna+shcontrol/scramble+shRNA+(Plasmid+%231864)/pm42776838-284-232-235
    Average 96 stars, based on 1 article reviews
    virus strains shcontrol addgene - by Bioz Stars, 2026-10
    96/100 stars
      Buy from Supplier

    86
    Sangon Biotech non targeting control short hairpin rna shcontrol llc phosphate buffered saline
    Ribavirin has synergistic effects on 5′-adenosine monophosphate (AMP)-activated protein kinase (AMPK) downregulation. (A) Three AMPK-targeting short hairpin RNAs (shRNAs) were screened to evaluate their knockdown efficiency and suppress AMPK expression in lung cancer cells. The data shown are representative of n = 3 biological replicates. (B) Tumor anatomy of mouse Lewis lung carcinoma (LLC) cells subcutaneous tumor-bearing mice in different treatment groups. (C) Tumor volume of LLC subcutaneous tumor-bearing mice in different treatment groups. Statistical significance between datasets was assessed by one-way analysis of variance (ANOVA), followed by Tukey’s multiple comparisons post hoc test between all groups. The values are the means ± standard error of the mean (SEM); n = 8 mice per group, with differences denoted by ∗ P < 0.05 and ∗∗ P < 0.01. (D) Tumor weights of LLC subcutaneous tumor-bearing mice in different treatment groups. Statistical significance between datasets was assessed by one-way ANOVA, followed by Tukey’s multiple comparisons post hoc test between all groups. The values are the means ± SEM; n = 8 mice per group, with differences denoted by ∗ P < 0.05, ∗∗ P < 0.01, and ∗∗∗ P < 0.001. (E) Schematic illustration of the mechanism by which Ribavirin regulates AMPK activation. AMPK is phosphorylated in response to an increased AMP/adenosine triphosphate (ATP) or adenosine diphosphate (ADP)/ATP ratio, influencing cell growth and proliferation by inactivating mechanistic target of rapamycin complex 1 (mTORC1). Ribavirin exerts its regulatory effect by inhibiting AMPK phosphorylation. Created with www.BioRender.com . <t>shControl:</t> <t>non-targeting</t> control short hairpin <t>RNA;</t> shAMPKα: AMPKα-targeting short hairpin RNA; GAPDH: glyceraldehyde-3-phosphate dehydrogenase; PBS: phosphate buffered saline; mTOR: mechanistic target of rapamycin; Raptor: regulatory-associated protein of mTOR; Deptor: DEP domain-containing mTOR-interacting protein; PRAS40: proline-rich Akt substrate of 40 kDa; mLST8: mammalian lethal with SEC13 protein 8; 4EBP1:eukaryotic translation initiation factor 4E-binding protein 1; P: phosphorylation.
    Non Targeting Control Short Hairpin Rna Shcontrol Llc Phosphate Buffered Saline, supplied by Sangon Biotech, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/shrna+shcontrol/buffered+phosphate+saline/pmc12962084-75-13-24
    Average 86 stars, based on 1 article reviews
    non targeting control short hairpin rna shcontrol llc phosphate buffered saline - by Bioz Stars, 2026-10
    86/100 stars
      Buy from Supplier

    96
    Addgene inc scramble shrna shcontrol
    Ribavirin has synergistic effects on 5′-adenosine monophosphate (AMP)-activated protein kinase (AMPK) downregulation. (A) Three AMPK-targeting short hairpin RNAs (shRNAs) were screened to evaluate their knockdown efficiency and suppress AMPK expression in lung cancer cells. The data shown are representative of n = 3 biological replicates. (B) Tumor anatomy of mouse Lewis lung carcinoma (LLC) cells subcutaneous tumor-bearing mice in different treatment groups. (C) Tumor volume of LLC subcutaneous tumor-bearing mice in different treatment groups. Statistical significance between datasets was assessed by one-way analysis of variance (ANOVA), followed by Tukey’s multiple comparisons post hoc test between all groups. The values are the means ± standard error of the mean (SEM); n = 8 mice per group, with differences denoted by ∗ P < 0.05 and ∗∗ P < 0.01. (D) Tumor weights of LLC subcutaneous tumor-bearing mice in different treatment groups. Statistical significance between datasets was assessed by one-way ANOVA, followed by Tukey’s multiple comparisons post hoc test between all groups. The values are the means ± SEM; n = 8 mice per group, with differences denoted by ∗ P < 0.05, ∗∗ P < 0.01, and ∗∗∗ P < 0.001. (E) Schematic illustration of the mechanism by which Ribavirin regulates AMPK activation. AMPK is phosphorylated in response to an increased AMP/adenosine triphosphate (ATP) or adenosine diphosphate (ADP)/ATP ratio, influencing cell growth and proliferation by inactivating mechanistic target of rapamycin complex 1 (mTORC1). Ribavirin exerts its regulatory effect by inhibiting AMPK phosphorylation. Created with www.BioRender.com . <t>shControl:</t> <t>non-targeting</t> control short hairpin <t>RNA;</t> shAMPKα: AMPKα-targeting short hairpin RNA; GAPDH: glyceraldehyde-3-phosphate dehydrogenase; PBS: phosphate buffered saline; mTOR: mechanistic target of rapamycin; Raptor: regulatory-associated protein of mTOR; Deptor: DEP domain-containing mTOR-interacting protein; PRAS40: proline-rich Akt substrate of 40 kDa; mLST8: mammalian lethal with SEC13 protein 8; 4EBP1:eukaryotic translation initiation factor 4E-binding protein 1; P: phosphorylation.
    Scramble Shrna Shcontrol, supplied by Addgene inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/shrna+shcontrol/scramble+shRNA+(Plasmid+%231864)/pm41186628-40-5-8
    Average 96 stars, based on 1 article reviews
    scramble shrna shcontrol - by Bioz Stars, 2026-10
    96/100 stars
      Buy from Supplier

    86
    Sangon Biotech control shrna shcontrol
    Ribavirin has synergistic effects on 5′-adenosine monophosphate (AMP)-activated protein kinase (AMPK) downregulation. (A) Three AMPK-targeting short hairpin RNAs (shRNAs) were screened to evaluate their knockdown efficiency and suppress AMPK expression in lung cancer cells. The data shown are representative of n = 3 biological replicates. (B) Tumor anatomy of mouse Lewis lung carcinoma (LLC) cells subcutaneous tumor-bearing mice in different treatment groups. (C) Tumor volume of LLC subcutaneous tumor-bearing mice in different treatment groups. Statistical significance between datasets was assessed by one-way analysis of variance (ANOVA), followed by Tukey’s multiple comparisons post hoc test between all groups. The values are the means ± standard error of the mean (SEM); n = 8 mice per group, with differences denoted by ∗ P < 0.05 and ∗∗ P < 0.01. (D) Tumor weights of LLC subcutaneous tumor-bearing mice in different treatment groups. Statistical significance between datasets was assessed by one-way ANOVA, followed by Tukey’s multiple comparisons post hoc test between all groups. The values are the means ± SEM; n = 8 mice per group, with differences denoted by ∗ P < 0.05, ∗∗ P < 0.01, and ∗∗∗ P < 0.001. (E) Schematic illustration of the mechanism by which Ribavirin regulates AMPK activation. AMPK is phosphorylated in response to an increased AMP/adenosine triphosphate (ATP) or adenosine diphosphate (ADP)/ATP ratio, influencing cell growth and proliferation by inactivating mechanistic target of rapamycin complex 1 (mTORC1). Ribavirin exerts its regulatory effect by inhibiting AMPK phosphorylation. Created with www.BioRender.com . <t>shControl:</t> <t>non-targeting</t> control short hairpin <t>RNA;</t> shAMPKα: AMPKα-targeting short hairpin RNA; GAPDH: glyceraldehyde-3-phosphate dehydrogenase; PBS: phosphate buffered saline; mTOR: mechanistic target of rapamycin; Raptor: regulatory-associated protein of mTOR; Deptor: DEP domain-containing mTOR-interacting protein; PRAS40: proline-rich Akt substrate of 40 kDa; mLST8: mammalian lethal with SEC13 protein 8; 4EBP1:eukaryotic translation initiation factor 4E-binding protein 1; P: phosphorylation.
    Control Shrna Shcontrol, supplied by Sangon Biotech, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/shrna+shcontrol/control+shrna/pm41084177-84-7-16
    Average 86 stars, based on 1 article reviews
    control shrna shcontrol - by Bioz Stars, 2026-10
    86/100 stars
      Buy from Supplier

    94
    Addgene inc aav u6 shcontrol ef1a yfp plasmid
    Ribavirin has synergistic effects on 5′-adenosine monophosphate (AMP)-activated protein kinase (AMPK) downregulation. (A) Three AMPK-targeting short hairpin RNAs (shRNAs) were screened to evaluate their knockdown efficiency and suppress AMPK expression in lung cancer cells. The data shown are representative of n = 3 biological replicates. (B) Tumor anatomy of mouse Lewis lung carcinoma (LLC) cells subcutaneous tumor-bearing mice in different treatment groups. (C) Tumor volume of LLC subcutaneous tumor-bearing mice in different treatment groups. Statistical significance between datasets was assessed by one-way analysis of variance (ANOVA), followed by Tukey’s multiple comparisons post hoc test between all groups. The values are the means ± standard error of the mean (SEM); n = 8 mice per group, with differences denoted by ∗ P < 0.05 and ∗∗ P < 0.01. (D) Tumor weights of LLC subcutaneous tumor-bearing mice in different treatment groups. Statistical significance between datasets was assessed by one-way ANOVA, followed by Tukey’s multiple comparisons post hoc test between all groups. The values are the means ± SEM; n = 8 mice per group, with differences denoted by ∗ P < 0.05, ∗∗ P < 0.01, and ∗∗∗ P < 0.001. (E) Schematic illustration of the mechanism by which Ribavirin regulates AMPK activation. AMPK is phosphorylated in response to an increased AMP/adenosine triphosphate (ATP) or adenosine diphosphate (ADP)/ATP ratio, influencing cell growth and proliferation by inactivating mechanistic target of rapamycin complex 1 (mTORC1). Ribavirin exerts its regulatory effect by inhibiting AMPK phosphorylation. Created with www.BioRender.com . <t>shControl:</t> <t>non-targeting</t> control short hairpin <t>RNA;</t> shAMPKα: AMPKα-targeting short hairpin RNA; GAPDH: glyceraldehyde-3-phosphate dehydrogenase; PBS: phosphate buffered saline; mTOR: mechanistic target of rapamycin; Raptor: regulatory-associated protein of mTOR; Deptor: DEP domain-containing mTOR-interacting protein; PRAS40: proline-rich Akt substrate of 40 kDa; mLST8: mammalian lethal with SEC13 protein 8; 4EBP1:eukaryotic translation initiation factor 4E-binding protein 1; P: phosphorylation.
    Aav U6 Shcontrol Ef1a Yfp Plasmid, supplied by Addgene inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/shrna+shcontrol/AAV-shRNA-ctrl+(Plasmid+%2385741)/pmc12456964-122-0-3
    Average 94 stars, based on 1 article reviews
    aav u6 shcontrol ef1a yfp plasmid - by Bioz Stars, 2026-10
    94/100 stars
      Buy from Supplier

    93
    Addgene inc non targeting control shrna shcontrol
    CXCR4 regulates TSCC cell proliferation, migration, invasion, and EMT. a Cell proliferation assessed by CCK-8 assay in CAL-27 cells with different CXCR4 expression levels (Control, <t>shControl,</t> <t>shRNA-CXCR4-KD,</t> and shRNA-CXCR4-OE). b Colony formation assay of CAL-27 cells with different CXCR4 expression levels. Representative images (left) and quantification (right). c Transwell migration assay of CAL-27 cells with different CXCR4 expression levels. Representative images (left) and quantification (right). Scale bars, 100 μm. d Transwell invasion assay of CAL-27 cells with different CXCR4 expression levels. Representative images (left) and quantification (right). Scale bars, 100 μm. e Quantification of apoptotic cells measured by flow cytometry. f Representative flow cytometry plots showing apoptosis in CAL-27 cells with different CXCR4 expression levels. g Western blot analysis of EMT markers (E-cadherin, N-cadherin, and Vimentin) in CAL-27 cells with different CXCR4 expression levels. h qRT-PCR analysis of EMT markers in CAL-27 cells with different CXCR4 expression levels. i Wound healing assay showing the effect of CXCL12 on CAL-27 cell migration. Representative images (left) and quantification (right). Scale bars, 100 μm. j Real-time cell analysis (RTCA) showing the effect of CXCL12 on CAL-27 cell migration. Data are presented as mean ± SD from three independent experiments. *p < 0.05 , **p < 0.01 , ***p < 0.001 , ****p < 0.0001 (compared to Control or Serum-Free); # p < 0.05 , ## p < 0.01 , #### p < 0.0001 (compared to shControl or Blank-Serum); && p < 0.01 , &&&& p < 0.0001 (compared to shControl- CXCR4-KD)
    Non Targeting Control Shrna Shcontrol, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/shrna+shcontrol/pLKO%2E1+shControl+(Plasmid+%2374972)/pmc12239490-93-7-22
    Average 93 stars, based on 1 article reviews
    non targeting control shrna shcontrol - by Bioz Stars, 2026-10
    93/100 stars
      Buy from Supplier

    96
    Addgene inc shrna shcontrol
    Morphology, viability and proliferation of EA.hy926 cells after treatment with shHSPD1-A549 and <t>shControl-A549</t> secretomes. (A) Morphology of EA.hy926 cells observed under an inverted microscope, captured at x100 magnification. (B) Viability of EA.hy926 cells after 24-h treatment with secretomes, determined by MTT assay. Data are presented as a percentage of the untreated control. (C) Proliferation of EA.hy926 cells measured using the BrdU assay after 24-h treatment with secretomes. Data are shown as a fold change relative to the untreated control. Bar graphs represent mean ± SD from three independent experiments. * P<0.05. sh, short hairpin.
    Shrna Shcontrol, supplied by Addgene inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/shrna+shcontrol/shRNA+(Plasmid+%2355783)/pmc11904756-47-2-35
    Average 96 stars, based on 1 article reviews
    shrna shcontrol - by Bioz Stars, 2026-10
    96/100 stars
      Buy from Supplier

    96
    OriGene shcontrol
    Morphology, viability and proliferation of EA.hy926 cells after treatment with shHSPD1-A549 and <t>shControl-A549</t> secretomes. (A) Morphology of EA.hy926 cells observed under an inverted microscope, captured at x100 magnification. (B) Viability of EA.hy926 cells after 24-h treatment with secretomes, determined by MTT assay. Data are presented as a percentage of the untreated control. (C) Proliferation of EA.hy926 cells measured using the BrdU assay after 24-h treatment with secretomes. Data are shown as a fold change relative to the untreated control. Bar graphs represent mean ± SD from three independent experiments. * P<0.05. sh, short hairpin.
    Shcontrol, supplied by OriGene, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/shrna+shcontrol/Scrambled+shRNA+control+in+pGFP-C-shLenti+shRNA+Vector/pm40240814-210-14-16
    Average 96 stars, based on 1 article reviews
    shcontrol - by Bioz Stars, 2026-10
    96/100 stars
      Buy from Supplier

    96
    Santa Cruz Biotechnology shcontrol particles
    A-B) SNU449 survival rates (n=3 each) (A) post-thermal exposure at 37°C and 47°C at 24, 48, and 72 hours. Corresponding cell growth (B) . C) Western blot of Gal-1 in SNU449, SNU423, and HepG2/C3a (positive control). β-Tubulin was used to as loading control. D-E) SNU449 cell growth (n=3 each) (D) post-thermal exposure at 37°C and 47°C with Gal-1 inhibitor OTX or DMSO at 24, 48, and 72 hours. Corresponding cell survival rates (E) . F) Western blot of Gal-1 in shGal-1-SNU449 (SNU449 with Gal-1 knockdown) and respective <t>shControl-SNU449.</t> G-H) shControl and shGal-1-SNU449 cell growth (n=3) (G) post-thermal exposure at 37°C and 47°C at 24, 48, and 72 hours. Corresponding cell survival rates (H) . p-values were calculated using one-tailed-unpaired student’s t-test, *p<0.05, **p<0.01, ***p<0.001.
    Shcontrol Particles, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/shrna+shcontrol/Control+shRNA+Lentiviral+Particles-A/bio_rxiv__2024__12__12__628238-111-36-39
    Average 96 stars, based on 1 article reviews
    shcontrol particles - by Bioz Stars, 2026-10
    96/100 stars
      Buy from Supplier

    90
    Obio Technology Corp Ltd shrna negative control (shcontrol
    A-B) SNU449 survival rates (n=3 each) (A) post-thermal exposure at 37°C and 47°C at 24, 48, and 72 hours. Corresponding cell growth (B) . C) Western blot of Gal-1 in SNU449, SNU423, and HepG2/C3a (positive control). β-Tubulin was used to as loading control. D-E) SNU449 cell growth (n=3 each) (D) post-thermal exposure at 37°C and 47°C with Gal-1 inhibitor OTX or DMSO at 24, 48, and 72 hours. Corresponding cell survival rates (E) . F) Western blot of Gal-1 in shGal-1-SNU449 (SNU449 with Gal-1 knockdown) and respective <t>shControl-SNU449.</t> G-H) shControl and shGal-1-SNU449 cell growth (n=3) (G) post-thermal exposure at 37°C and 47°C at 24, 48, and 72 hours. Corresponding cell survival rates (H) . p-values were calculated using one-tailed-unpaired student’s t-test, *p<0.05, **p<0.01, ***p<0.001.
    Shrna Negative Control (Shcontrol, supplied by Obio Technology Corp Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/shrna+shcontrol/negative+control+plasmid/10__3390_slash_cells13231936-77-14-21
    Average 90 stars, based on 1 article reviews
    shrna negative control (shcontrol - by Bioz Stars, 2026-10
    90/100 stars
      Buy from Supplier

    Image Search Results


    Ribavirin has synergistic effects on 5′-adenosine monophosphate (AMP)-activated protein kinase (AMPK) downregulation. (A) Three AMPK-targeting short hairpin RNAs (shRNAs) were screened to evaluate their knockdown efficiency and suppress AMPK expression in lung cancer cells. The data shown are representative of n = 3 biological replicates. (B) Tumor anatomy of mouse Lewis lung carcinoma (LLC) cells subcutaneous tumor-bearing mice in different treatment groups. (C) Tumor volume of LLC subcutaneous tumor-bearing mice in different treatment groups. Statistical significance between datasets was assessed by one-way analysis of variance (ANOVA), followed by Tukey’s multiple comparisons post hoc test between all groups. The values are the means ± standard error of the mean (SEM); n = 8 mice per group, with differences denoted by ∗ P < 0.05 and ∗∗ P < 0.01. (D) Tumor weights of LLC subcutaneous tumor-bearing mice in different treatment groups. Statistical significance between datasets was assessed by one-way ANOVA, followed by Tukey’s multiple comparisons post hoc test between all groups. The values are the means ± SEM; n = 8 mice per group, with differences denoted by ∗ P < 0.05, ∗∗ P < 0.01, and ∗∗∗ P < 0.001. (E) Schematic illustration of the mechanism by which Ribavirin regulates AMPK activation. AMPK is phosphorylated in response to an increased AMP/adenosine triphosphate (ATP) or adenosine diphosphate (ADP)/ATP ratio, influencing cell growth and proliferation by inactivating mechanistic target of rapamycin complex 1 (mTORC1). Ribavirin exerts its regulatory effect by inhibiting AMPK phosphorylation. Created with www.BioRender.com . shControl: non-targeting control short hairpin RNA; shAMPKα: AMPKα-targeting short hairpin RNA; GAPDH: glyceraldehyde-3-phosphate dehydrogenase; PBS: phosphate buffered saline; mTOR: mechanistic target of rapamycin; Raptor: regulatory-associated protein of mTOR; Deptor: DEP domain-containing mTOR-interacting protein; PRAS40: proline-rich Akt substrate of 40 kDa; mLST8: mammalian lethal with SEC13 protein 8; 4EBP1:eukaryotic translation initiation factor 4E-binding protein 1; P: phosphorylation.

    Journal: Journal of Pharmaceutical Analysis

    Article Title: Oblique-incidence reflectivity difference technology identifies the antiviral drug Ribavirin as an inhibitor of lung tumor progression by targeting AMPK signaling

    doi: 10.1016/j.jpha.2025.101306

    Figure Lengend Snippet: Ribavirin has synergistic effects on 5′-adenosine monophosphate (AMP)-activated protein kinase (AMPK) downregulation. (A) Three AMPK-targeting short hairpin RNAs (shRNAs) were screened to evaluate their knockdown efficiency and suppress AMPK expression in lung cancer cells. The data shown are representative of n = 3 biological replicates. (B) Tumor anatomy of mouse Lewis lung carcinoma (LLC) cells subcutaneous tumor-bearing mice in different treatment groups. (C) Tumor volume of LLC subcutaneous tumor-bearing mice in different treatment groups. Statistical significance between datasets was assessed by one-way analysis of variance (ANOVA), followed by Tukey’s multiple comparisons post hoc test between all groups. The values are the means ± standard error of the mean (SEM); n = 8 mice per group, with differences denoted by ∗ P < 0.05 and ∗∗ P < 0.01. (D) Tumor weights of LLC subcutaneous tumor-bearing mice in different treatment groups. Statistical significance between datasets was assessed by one-way ANOVA, followed by Tukey’s multiple comparisons post hoc test between all groups. The values are the means ± SEM; n = 8 mice per group, with differences denoted by ∗ P < 0.05, ∗∗ P < 0.01, and ∗∗∗ P < 0.001. (E) Schematic illustration of the mechanism by which Ribavirin regulates AMPK activation. AMPK is phosphorylated in response to an increased AMP/adenosine triphosphate (ATP) or adenosine diphosphate (ADP)/ATP ratio, influencing cell growth and proliferation by inactivating mechanistic target of rapamycin complex 1 (mTORC1). Ribavirin exerts its regulatory effect by inhibiting AMPK phosphorylation. Created with www.BioRender.com . shControl: non-targeting control short hairpin RNA; shAMPKα: AMPKα-targeting short hairpin RNA; GAPDH: glyceraldehyde-3-phosphate dehydrogenase; PBS: phosphate buffered saline; mTOR: mechanistic target of rapamycin; Raptor: regulatory-associated protein of mTOR; Deptor: DEP domain-containing mTOR-interacting protein; PRAS40: proline-rich Akt substrate of 40 kDa; mLST8: mammalian lethal with SEC13 protein 8; 4EBP1:eukaryotic translation initiation factor 4E-binding protein 1; P: phosphorylation.

    Article Snippet: The mice were randomly divided into four groups ( n = 8): the non-targeting control short hairpin RNA (shControl)-LLC + phosphate buffered saline (PBS) (Sangon Biotech, Shanghai, China) group, shControl-LLC + Ribavirin group, shAMPKα-LLC + PBS group, and shAMPKα-LLC + Ribavirin group.

    Techniques: Knockdown, Expressing, Activation Assay, Phospho-proteomics, Control, shRNA, Saline, Binding Assay

    CXCR4 regulates TSCC cell proliferation, migration, invasion, and EMT. a Cell proliferation assessed by CCK-8 assay in CAL-27 cells with different CXCR4 expression levels (Control, shControl, shRNA-CXCR4-KD, and shRNA-CXCR4-OE). b Colony formation assay of CAL-27 cells with different CXCR4 expression levels. Representative images (left) and quantification (right). c Transwell migration assay of CAL-27 cells with different CXCR4 expression levels. Representative images (left) and quantification (right). Scale bars, 100 μm. d Transwell invasion assay of CAL-27 cells with different CXCR4 expression levels. Representative images (left) and quantification (right). Scale bars, 100 μm. e Quantification of apoptotic cells measured by flow cytometry. f Representative flow cytometry plots showing apoptosis in CAL-27 cells with different CXCR4 expression levels. g Western blot analysis of EMT markers (E-cadherin, N-cadherin, and Vimentin) in CAL-27 cells with different CXCR4 expression levels. h qRT-PCR analysis of EMT markers in CAL-27 cells with different CXCR4 expression levels. i Wound healing assay showing the effect of CXCL12 on CAL-27 cell migration. Representative images (left) and quantification (right). Scale bars, 100 μm. j Real-time cell analysis (RTCA) showing the effect of CXCL12 on CAL-27 cell migration. Data are presented as mean ± SD from three independent experiments. *p < 0.05 , **p < 0.01 , ***p < 0.001 , ****p < 0.0001 (compared to Control or Serum-Free); # p < 0.05 , ## p < 0.01 , #### p < 0.0001 (compared to shControl or Blank-Serum); && p < 0.01 , &&&& p < 0.0001 (compared to shControl- CXCR4-KD)

    Journal: Journal of Translational Medicine

    Article Title: CXCR4/CXCL12 axis promotes lymphatic metastasis in tongue squamous cell carcinoma via PI3K/AKT signaling pathway

    doi: 10.1186/s12967-025-06707-9

    Figure Lengend Snippet: CXCR4 regulates TSCC cell proliferation, migration, invasion, and EMT. a Cell proliferation assessed by CCK-8 assay in CAL-27 cells with different CXCR4 expression levels (Control, shControl, shRNA-CXCR4-KD, and shRNA-CXCR4-OE). b Colony formation assay of CAL-27 cells with different CXCR4 expression levels. Representative images (left) and quantification (right). c Transwell migration assay of CAL-27 cells with different CXCR4 expression levels. Representative images (left) and quantification (right). Scale bars, 100 μm. d Transwell invasion assay of CAL-27 cells with different CXCR4 expression levels. Representative images (left) and quantification (right). Scale bars, 100 μm. e Quantification of apoptotic cells measured by flow cytometry. f Representative flow cytometry plots showing apoptosis in CAL-27 cells with different CXCR4 expression levels. g Western blot analysis of EMT markers (E-cadherin, N-cadherin, and Vimentin) in CAL-27 cells with different CXCR4 expression levels. h qRT-PCR analysis of EMT markers in CAL-27 cells with different CXCR4 expression levels. i Wound healing assay showing the effect of CXCL12 on CAL-27 cell migration. Representative images (left) and quantification (right). Scale bars, 100 μm. j Real-time cell analysis (RTCA) showing the effect of CXCL12 on CAL-27 cell migration. Data are presented as mean ± SD from three independent experiments. *p < 0.05 , **p < 0.01 , ***p < 0.001 , ****p < 0.0001 (compared to Control or Serum-Free); # p < 0.05 , ## p < 0.01 , #### p < 0.0001 (compared to shControl or Blank-Serum); && p < 0.01 , &&&& p < 0.0001 (compared to shControl- CXCR4-KD)

    Article Snippet: Lentiviral vectors expressing CXCR4 shRNA (shCXCR4) or non-targeting control shRNA (shControl) were constructed by cloning the target sequences into the pLKO.1 vector (Addgene, Cat10878).

    Techniques: Migration, CCK-8 Assay, Expressing, Control, shRNA, Colony Assay, Transwell Migration Assay, Transwell Invasion Assay, Flow Cytometry, Western Blot, Quantitative RT-PCR, Wound Healing Assay, Cell Analysis

    Morphology, viability and proliferation of EA.hy926 cells after treatment with shHSPD1-A549 and shControl-A549 secretomes. (A) Morphology of EA.hy926 cells observed under an inverted microscope, captured at x100 magnification. (B) Viability of EA.hy926 cells after 24-h treatment with secretomes, determined by MTT assay. Data are presented as a percentage of the untreated control. (C) Proliferation of EA.hy926 cells measured using the BrdU assay after 24-h treatment with secretomes. Data are shown as a fold change relative to the untreated control. Bar graphs represent mean ± SD from three independent experiments. * P<0.05. sh, short hairpin.

    Journal: Biomedical Reports

    Article Title: Heat shock protein family D member 1 mediates lung cancer cell‑induced angiogenesis of endothelial cells

    doi: 10.3892/br.2025.1955

    Figure Lengend Snippet: Morphology, viability and proliferation of EA.hy926 cells after treatment with shHSPD1-A549 and shControl-A549 secretomes. (A) Morphology of EA.hy926 cells observed under an inverted microscope, captured at x100 magnification. (B) Viability of EA.hy926 cells after 24-h treatment with secretomes, determined by MTT assay. Data are presented as a percentage of the untreated control. (C) Proliferation of EA.hy926 cells measured using the BrdU assay after 24-h treatment with secretomes. Data are shown as a fold change relative to the untreated control. Bar graphs represent mean ± SD from three independent experiments. * P<0.05. sh, short hairpin.

    Article Snippet: The scrambled shRNA (shControl) with the oligonucleotide sequence: 5'-CCTAAGGTTAAGTCGCCCTCGCTCGAGCGAGGGCGACTTAACCTTAGG-3' inserted into the pLKO.1-puro plasmid (a gift from Dr David Sabatini, Whitehead Institute for Biomedical Research and Department of Biology, Massachusetts Institute of Technology, MA, USA; Addgene plasmid no. 1864) served as a negative control.

    Techniques: Inverted Microscopy, MTT Assay, Control, BrdU Staining

    Cell migration capability of EA.hy926 cells after treatment with shHSPD1-A549 and shControl-A549 secretomes. (A) Representative images of the wound area captured at 0, 8, 16 and 24 h after secretome treatment, captured at x100 magnification. (B) Percentage of wound healing. Data are presented as mean ± SD from three independent experiments. * P<0.05. sh, short hairpin; HSPD1, heat shock protein family D member 1.

    Journal: Biomedical Reports

    Article Title: Heat shock protein family D member 1 mediates lung cancer cell‑induced angiogenesis of endothelial cells

    doi: 10.3892/br.2025.1955

    Figure Lengend Snippet: Cell migration capability of EA.hy926 cells after treatment with shHSPD1-A549 and shControl-A549 secretomes. (A) Representative images of the wound area captured at 0, 8, 16 and 24 h after secretome treatment, captured at x100 magnification. (B) Percentage of wound healing. Data are presented as mean ± SD from three independent experiments. * P<0.05. sh, short hairpin; HSPD1, heat shock protein family D member 1.

    Article Snippet: The scrambled shRNA (shControl) with the oligonucleotide sequence: 5'-CCTAAGGTTAAGTCGCCCTCGCTCGAGCGAGGGCGACTTAACCTTAGG-3' inserted into the pLKO.1-puro plasmid (a gift from Dr David Sabatini, Whitehead Institute for Biomedical Research and Department of Biology, Massachusetts Institute of Technology, MA, USA; Addgene plasmid no. 1864) served as a negative control.

    Techniques: Migration

    Cell invasion of EA.hy926 cells after treatment with shHSPD1-A549 and shControl-A549 secretomes. (A) Representative images of crystal violet-stained EA.hy926 cells after 24-h treatment with secretomes, captured at x100 magnification. (B) The optical density of crystal violet-stained cells at 590 nm. Data are presented as mean ± SD from three independent experiments and expressed as a fold change relative to the untreated control. *** P<0.001. sh, short hairpin; HSPD1, heat shock protein family D member 1.

    Journal: Biomedical Reports

    Article Title: Heat shock protein family D member 1 mediates lung cancer cell‑induced angiogenesis of endothelial cells

    doi: 10.3892/br.2025.1955

    Figure Lengend Snippet: Cell invasion of EA.hy926 cells after treatment with shHSPD1-A549 and shControl-A549 secretomes. (A) Representative images of crystal violet-stained EA.hy926 cells after 24-h treatment with secretomes, captured at x100 magnification. (B) The optical density of crystal violet-stained cells at 590 nm. Data are presented as mean ± SD from three independent experiments and expressed as a fold change relative to the untreated control. *** P<0.001. sh, short hairpin; HSPD1, heat shock protein family D member 1.

    Article Snippet: The scrambled shRNA (shControl) with the oligonucleotide sequence: 5'-CCTAAGGTTAAGTCGCCCTCGCTCGAGCGAGGGCGACTTAACCTTAGG-3' inserted into the pLKO.1-puro plasmid (a gift from Dr David Sabatini, Whitehead Institute for Biomedical Research and Department of Biology, Massachusetts Institute of Technology, MA, USA; Addgene plasmid no. 1864) served as a negative control.

    Techniques: Staining, Control

    Cell aggregation of EA.hy926 cells following treatment with shHSPD1-A549 and shControl-A549 secretomes. (A) Representative images of EA.hy926 cell aggregates after secretome treatment, captured at x100 magnification. (B) Size of cell aggregates. Data are presented as mean ± SD from three independent experiments. * P<0.05, ** P<0.01. sh, short hairpin; HSPD1, heat shock protein family D member 1.

    Journal: Biomedical Reports

    Article Title: Heat shock protein family D member 1 mediates lung cancer cell‑induced angiogenesis of endothelial cells

    doi: 10.3892/br.2025.1955

    Figure Lengend Snippet: Cell aggregation of EA.hy926 cells following treatment with shHSPD1-A549 and shControl-A549 secretomes. (A) Representative images of EA.hy926 cell aggregates after secretome treatment, captured at x100 magnification. (B) Size of cell aggregates. Data are presented as mean ± SD from three independent experiments. * P<0.05, ** P<0.01. sh, short hairpin; HSPD1, heat shock protein family D member 1.

    Article Snippet: The scrambled shRNA (shControl) with the oligonucleotide sequence: 5'-CCTAAGGTTAAGTCGCCCTCGCTCGAGCGAGGGCGACTTAACCTTAGG-3' inserted into the pLKO.1-puro plasmid (a gift from Dr David Sabatini, Whitehead Institute for Biomedical Research and Department of Biology, Massachusetts Institute of Technology, MA, USA; Addgene plasmid no. 1864) served as a negative control.

    Techniques:

    Endothelial tube formation of EA.hy926 cells after treatment with shHSPD1-A549 and shControl-A549 secretomes. (A) Representative images of tube formation in EA.hy926 cells after secretome treatment, captured at x40 magnification with additional zoomed-in areas. (B) Length of formed tubes. (C) Area of formed tubes. Data are presented as mean ± SD from three independent experiments. * P<0.05. sh, short hairpin; HSPD1, heat shock protein family D member 1.

    Journal: Biomedical Reports

    Article Title: Heat shock protein family D member 1 mediates lung cancer cell‑induced angiogenesis of endothelial cells

    doi: 10.3892/br.2025.1955

    Figure Lengend Snippet: Endothelial tube formation of EA.hy926 cells after treatment with shHSPD1-A549 and shControl-A549 secretomes. (A) Representative images of tube formation in EA.hy926 cells after secretome treatment, captured at x40 magnification with additional zoomed-in areas. (B) Length of formed tubes. (C) Area of formed tubes. Data are presented as mean ± SD from three independent experiments. * P<0.05. sh, short hairpin; HSPD1, heat shock protein family D member 1.

    Article Snippet: The scrambled shRNA (shControl) with the oligonucleotide sequence: 5'-CCTAAGGTTAAGTCGCCCTCGCTCGAGCGAGGGCGACTTAACCTTAGG-3' inserted into the pLKO.1-puro plasmid (a gift from Dr David Sabatini, Whitehead Institute for Biomedical Research and Department of Biology, Massachusetts Institute of Technology, MA, USA; Addgene plasmid no. 1864) served as a negative control.

    Techniques:

    VEGF levels in the culture supernatant of EA.hy926 cells after treatment with shHSPD1-A549 and shControl-A549 secretomes. VEGF levels were measured by ELISA. The bar graph represents mean ± SD from three independent experiments. * P<0.05, ** P<0.01. VEGF, vascular endothelial growth factor; sh, short hairpin; HSPD1, heat shock protein family D member 1.

    Journal: Biomedical Reports

    Article Title: Heat shock protein family D member 1 mediates lung cancer cell‑induced angiogenesis of endothelial cells

    doi: 10.3892/br.2025.1955

    Figure Lengend Snippet: VEGF levels in the culture supernatant of EA.hy926 cells after treatment with shHSPD1-A549 and shControl-A549 secretomes. VEGF levels were measured by ELISA. The bar graph represents mean ± SD from three independent experiments. * P<0.05, ** P<0.01. VEGF, vascular endothelial growth factor; sh, short hairpin; HSPD1, heat shock protein family D member 1.

    Article Snippet: The scrambled shRNA (shControl) with the oligonucleotide sequence: 5'-CCTAAGGTTAAGTCGCCCTCGCTCGAGCGAGGGCGACTTAACCTTAGG-3' inserted into the pLKO.1-puro plasmid (a gift from Dr David Sabatini, Whitehead Institute for Biomedical Research and Department of Biology, Massachusetts Institute of Technology, MA, USA; Addgene plasmid no. 1864) served as a negative control.

    Techniques: Enzyme-linked Immunosorbent Assay

    A-B) SNU449 survival rates (n=3 each) (A) post-thermal exposure at 37°C and 47°C at 24, 48, and 72 hours. Corresponding cell growth (B) . C) Western blot of Gal-1 in SNU449, SNU423, and HepG2/C3a (positive control). β-Tubulin was used to as loading control. D-E) SNU449 cell growth (n=3 each) (D) post-thermal exposure at 37°C and 47°C with Gal-1 inhibitor OTX or DMSO at 24, 48, and 72 hours. Corresponding cell survival rates (E) . F) Western blot of Gal-1 in shGal-1-SNU449 (SNU449 with Gal-1 knockdown) and respective shControl-SNU449. G-H) shControl and shGal-1-SNU449 cell growth (n=3) (G) post-thermal exposure at 37°C and 47°C at 24, 48, and 72 hours. Corresponding cell survival rates (H) . p-values were calculated using one-tailed-unpaired student’s t-test, *p<0.05, **p<0.01, ***p<0.001.

    Journal: bioRxiv

    Article Title: Galectin-1 Modulates Hepatocellular Carcinoma Response to Thermal Ablation Through Regulating Glycolysis

    doi: 10.1101/2024.12.12.628238

    Figure Lengend Snippet: A-B) SNU449 survival rates (n=3 each) (A) post-thermal exposure at 37°C and 47°C at 24, 48, and 72 hours. Corresponding cell growth (B) . C) Western blot of Gal-1 in SNU449, SNU423, and HepG2/C3a (positive control). β-Tubulin was used to as loading control. D-E) SNU449 cell growth (n=3 each) (D) post-thermal exposure at 37°C and 47°C with Gal-1 inhibitor OTX or DMSO at 24, 48, and 72 hours. Corresponding cell survival rates (E) . F) Western blot of Gal-1 in shGal-1-SNU449 (SNU449 with Gal-1 knockdown) and respective shControl-SNU449. G-H) shControl and shGal-1-SNU449 cell growth (n=3) (G) post-thermal exposure at 37°C and 47°C at 24, 48, and 72 hours. Corresponding cell survival rates (H) . p-values were calculated using one-tailed-unpaired student’s t-test, *p<0.05, **p<0.01, ***p<0.001.

    Article Snippet: The following day, cells were transduced with lentiviral shRNA particles carrying three to five expression constructs each encoding target-specific 19-25 nucleotides (plus hairpin) shRNA designed to silence the gene expression of galectin-1 (sc-35441-V, scbt) or respective shControl particles (sc-108080, scbt).

    Techniques: Western Blot, Positive Control, Control, Knockdown, One-tailed Test